Compounds > 6-hydroxydopa quinone
Page last updated: 2024-09-03

6-hydroxydopa quinone and 6-cyano-7-nitroquinoxaline-2,3-dione

6-hydroxydopa quinone has been researched along with 6-cyano-7-nitroquinoxaline-2,3-dione in 1 studies

Compound Research Comparison

Studies
(6-hydroxydopa quinone)		Trials
(6-hydroxydopa quinone)		Recent Studies (post-2010)
(6-hydroxydopa quinone)		Studies
(6-cyano-7-nitroquinoxaline-2,3-dione)		Trials
(6-cyano-7-nitroquinoxaline-2,3-dione)		Recent Studies (post-2010) (6-cyano-7-nitroquinoxaline-2,3-dione)
1440142,6981353

Protein Interaction Comparison

ProteinTaxonomy6-hydroxydopa quinone (IC50)6-cyano-7-nitroquinoxaline-2,3-dione (IC50)
Glutamate receptor 1Homo sapiens (human)1.02
Glutamate receptor 2Homo sapiens (human)1.02
Glutamate receptor 3Homo sapiens (human)1.02
Glutamate receptor 4Homo sapiens (human)1.02

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Aizenman, E; Newcomer, TA; Rosenberg, PA1

Other Studies

1 other study(ies) available for 6-hydroxydopa quinone and 6-cyano-7-nitroquinoxaline-2,3-dione

ArticleYear
Iron-mediated oxidation of 3,4-dihydroxyphenylalanine to an excitotoxin.
    Journal of neurochemistry, 1995, Volume: 64, Issue:4

    Topics: 6-Cyano-7-nitroquinoxaline-2,3-dione; Animals; Ascorbic Acid; Cells, Cultured; Chromatography, High Pressure Liquid; Dihydroxyphenylalanine; Electrophysiology; Hydrogen Peroxide; Iron; Neurons; Neurotoxins; Oxidation-Reduction; Rats

1995